57th American Society of Hematology Annual Meeting
Billed as "the world's premier event in malignant & non-malignant hematology," this year's event will feature a top-notch faculty and "thousands of scientific abstracts highlighting updates in the hottest topics in hematology."
The phase three studies, B-LONG and Kids B-LONG, examined outcomes with a hemophilia B therapy in adults and adolescents. Now an extension study went further to verify the findings and the results were presented at the 57th American Society of Hematology Annual Meeting (ASH 2015) in Orlando, Florida.
Although the increased bleeding risk in patients with both acute and chronic liver disease is recognized, strategies to predict the occurrence are lacking. A team from South Korea discussed parameters to do just that during a poster session 57th American Society of Hematology Annual Meeting (ASH 2015) in Orlando, Florida.
Epoetin Alfa Biosimilar Increases Hemoglobin Levels in Anemic Patients Undergoing Chemotherapy for a Lymphoid Malignancy
Equations with Both Serum Cystatin C and Creatinine Inaccurately Estimate Glomerular Filtration Rate
Predictive Analytics: How Big Data Will Improve Outcomes and Efficiencies in Diagnosing and Treating Patients